These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10919259)

  • 61. Proteomic analysis of mouse islets after multiple low-dose streptozotocin injection.
    Xie X; Li S; Liu S; Lu Y; Shen P; Ji J
    Biochim Biophys Acta; 2008 Feb; 1784(2):276-84. PubMed ID: 18082151
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Islet Blood Flow in Multiple Low Dose Streptozotocin-Treated Wild-Type and Inducible Nitric Oxide Synthase-Deficient Mice.
    Carlsson PO; Flodstro M M; Sandler S
    Endocrinology; 2000 Aug; 141(8):2752-2757. PubMed ID: 28201243
    [No Abstract]   [Full Text] [Related]  

  • 63. Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice.
    Holstad M; Sandler S
    Autoimmunity; 1993; 15(4):311-4. PubMed ID: 8136460
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pancreatic islet blood flow and its measurement.
    Jansson L; Barbu A; Bodin B; Drott CJ; Espes D; Gao X; Grapensparr L; Källskog Ö; Lau J; Liljebäck H; Palm F; Quach M; Sandberg M; Strömberg V; Ullsten S; Carlsson PO
    Ups J Med Sci; 2016 May; 121(2):81-95. PubMed ID: 27124642
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ultrastructural observations on cytotoxic effector cells infiltrating pancreatic islets of low-dose streptozocin treated mice.
    Papaccio G; Esposito V
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(1):5-10. PubMed ID: 1531718
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-interleukin 2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice.
    Hatamori N; Yokono K; Hayakawa M; Taki T; Ogawa W; Nagata M; Hari J; Shii K; Taniguchi H; Baba S
    Diabetologia; 1990 May; 33(5):266-71. PubMed ID: 2142923
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation of peritoneal macrophages during the prediabetic phase in low-dose streptozotocin-treated mice.
    Andrade J; Conde M; Sobrino F; Bedoya FJ
    FEBS Lett; 1993 Jul; 327(1):32-4. PubMed ID: 7687564
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mice lacking inducible nitric oxide synthase develop spontaneous hypercholesterolaemia and aortic atheromas.
    Ihrig M; Dangler CA; Fox JG
    Atherosclerosis; 2001 May; 156(1):103-7. PubMed ID: 11369002
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alterations of islet microvasculature in mice treated with low-dose streptozocin.
    Papaccio G; Chieffi-Baccari G
    Histochemistry; 1992 May; 97(4):371-4. PubMed ID: 1535618
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Contrast-enhanced ultrasound measurement of pancreatic blood flow dynamics predicts type 1 diabetes progression in preclinical models.
    St Clair JR; Ramirez D; Passman S; Benninger RKP
    Nat Commun; 2018 May; 9(1):1742. PubMed ID: 29717116
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lymphocyte transfer in streptozotocin-induced diabetes: adhesion of donor cells to islet endothelium.
    Enghofer M; Bojunga J; Ludwig R; Oldenburg A; Bernd A; Usadel KH; Kusterer K
    Am J Physiol; 1998 May; 274(5):E928-35. PubMed ID: 9612252
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The low dose streptozotocin murine model of type 1 (insulin-dependent) diabetes mellitus: studies in vivo and in vitro of the modulating effect of sex hormones.
    Kromann H; Christy M; Lernmark A; Nedergaard M; Nerup J
    Diabetologia; 1982 Mar; 22(3):194-8. PubMed ID: 6210590
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dietary zinc supplementation inhibits NFkappaB activation and protects against chemically induced diabetes in CD1 mice.
    Ho E; Quan N; Tsai YH; Lai W; Bray TM
    Exp Biol Med (Maywood); 2001 Feb; 226(2):103-11. PubMed ID: 11446433
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocin-treated mice persists if essential fatty acid repletion occurs outside of a brief window of susceptibility.
    Wright JR; Haliburton B; Russell H; Henry M; Fraser R; Cook HW
    Diabetologia; 1991 Oct; 34(10):709-14. PubMed ID: 1835705
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diabetogenic action of streptozotocin: essential role of membrane permeability.
    Beppu H; Maruta K; Kürner T; Kolb H
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):90-5. PubMed ID: 2949474
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gangliosides prevent insulitis but not islet B cell destruction in low-dose streptozocin-treated mice.
    Papaccio G
    Diabetes Res Clin Pract; 1993 Jan; 19(1):9-15. PubMed ID: 8472624
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implications.
    Haluzík M; Nedvídková J
    Physiol Res; 2000; 49 Suppl 1():S37-42. PubMed ID: 10984070
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.
    Like AA; Rossini AA
    Science; 1976 Jul; 193(4251):415-7. PubMed ID: 180605
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CD18 deficiency protects against multiple low-dose streptozotocin-induced diabetes.
    Barlow SC; Langston W; Matthews KM; Chidlow JH; Kevil CG
    Am J Pathol; 2004 Dec; 165(6):1849-52. PubMed ID: 15579429
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro.
    Sandler S; Andersson A
    Diabetologia; 1982 Oct; 23(4):374-8. PubMed ID: 6292033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.